Home-Based Pulmonary Rehabilitation for Patients With Idiopathic Pulmonary Fibrosis: A PILOT STUDY
Overview
Affiliations
Purpose: To evaluate the adherence and effectiveness of a home-based exergame program for patients with idiopathic pulmonary fibrosis (IPF).
Method: Patients with IPF were randomly assigned to a relatively unsupervised Wii Fit exergame intervention group or Wii video game control group (with no active whole-body movement involved). Participants in both groups were instructed to play their respective games 30 min/d, 3 d/wk for 12 wk. In addition, they were asked to perform their usual exercise/physical activities. Outcome measures were 6-min walk distance (6MWD), exercise-related dyspnea, and St George's Respiratory Questionnaire (SGRQ).
Results: The 20 participants differed significantly between intervention and control groups in baseline characteristics (forced vital capacity = 2.0 ± 0.5 vs 3.1 ± 0.7 L; forced expiratory volume in 1 sec = 1.7 ± 0.4 vs 2.5 ± 0.6 L, respectively). Participant adherence rate to the exergame program was very low (20%). There was no significant improvement in the outcome measures in either group. In fact, both the intervention and control groups had a deterioration in 6MWD (-22 ± 56 m vs -60 ± 111 m), respectively and SGRQ scores (3 ± 9 vs 1 ± 11), respectively.
Conclusions: The home-based exergame intervention for patients with IPF did not show improvement in functional performance, dyspnea, or health-related quality of life at the completion of the 12-wk program in our 2 heterogeneous groups. In addition to the low adherence rate, insufficient frequencies and durations of exergaming may contribute to the lack of improvement. A lack of effectiveness of home-based pulmonary rehabilitation using exergaming for patients with IPF appears consistent with prior observational studies that used more traditional modes of home-based exercise.
Hernandez-Sanchez S, Roses-Conde J, Martinez-Llorens N, Ruiz D, Espejo-Antunez L, Tomas-Rodriguez I Sensors (Basel). 2024; 24(15).
PMID: 39123945 PMC: 11314742. DOI: 10.3390/s24154898.
Sanduzzi Zamparelli S, Lombardi C, Candia C, Iovine P, Rea G, Vitacca M J Clin Med. 2024; 13(7).
PMID: 38610791 PMC: 11012394. DOI: 10.3390/jcm13072026.
Brighton L, Spain N, Gonzalez-Nieto J, Ingram K, Harvey J, Man W BMJ Open Respir Res. 2024; 11(1).
PMID: 38378779 PMC: 10882322. DOI: 10.1136/bmjresp-2023-002061.
Amin R, Pandey R, Vaishali K, Acharya V, Sinha M, Kumar N Mini Rev Med Chem. 2023; 24(6):618-633.
PMID: 37587813 DOI: 10.2174/1389557523666230816090112.
Celik M, Pehlivan E Thorac Res Pract. 2023; 24(3):170-176.
PMID: 37503620 PMC: 10346104. DOI: 10.5152/ThoracResPract.2023.22150.